{"transactions":[{"id":714710,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:42.000Z","date":"2026-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":6818,"price":13.09,"value":89247.62,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F5","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on July 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on July 1, 2026."}],"balance_after":338053,"source":{"system":"sec-edgar","filing":"0001346164-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000006/primarydocument.xml","form_type":"4"}},{"id":714709,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:42.000Z","date":"2026-06-30","kind":"grant","planned":false,"acquired":true,"shares":1453,"price":10.18,"value":14791.54,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F3","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the ESPP for the ESPP purchase period of January 1, 2026 through June 30, 2026. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on June 30, 2026."}],"balance_after":344871,"source":{"system":"sec-edgar","filing":"0001346164-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000006/primarydocument.xml","form_type":"4"}},{"id":714708,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-07-06T20:51:42.000Z","date":"2025-12-31","kind":"grant","planned":false,"acquired":true,"shares":951,"price":6.9955,"value":6652.7205,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of shares of the Issuer's common stock pursuant to the REGENXBIO Inc. Employee Stock Purchase Plan (\"ESPP\") for the ESPP purchase period of July 1, 2025 through December 31, 2025. This transaction is exempt under Rule 16b-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased based on 85% of the closing price of the Issuer's common stock on July 1, 2025."}],"balance_after":343418,"source":{"system":"sec-edgar","filing":"0001346164-26-000006","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000006/primarydocument.xml","form_type":"4"}},{"id":943086,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2026-01-08T21:43:19.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":233651,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 6, 2027 while the optionee provides continuous service to the Issuer."}],"balance_after":233651,"derivative":{"exercise_price":14.18,"expiration_date":"2036-01-06","underlying":"Common Stock","underlying_shares":233651},"source":{"system":"sec-edgar","filing":"0001346164-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000004/primarydocument.xml","form_type":"4"}},{"id":943085,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-08T21:43:19.000Z","date":"2026-01-06","kind":"grant","planned":false,"acquired":true,"shares":144864,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 6, 2027, January 6, 2028, January 6, 2029 and January 6, 2030 while the recipient provides continuous service to the Issuer."}],"balance_after":342467,"source":{"system":"sec-edgar","filing":"0001346164-26-000004","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000004/primarydocument.xml","form_type":"4"}},{"id":945894,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2026-01-06T21:32:27.000Z","date":"2026-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":18559,"price":14.4,"value":267249.6,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 3, 2022, January 3, 2023, January 2, 2024 and January 2, 2025. The number of shares withheld was determined on January 2, 2026 based on the closing price of the issuer's common stock on December 31, 2025."}],"balance_after":197603,"source":{"system":"sec-edgar","filing":"0001346164-26-000002","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616426000002/primarydocument.xml","form_type":"4"}},{"id":1019988,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-10T22:38:07.000Z","date":"2025-10-09","kind":"sale","planned":true,"acquired":false,"shares":20811,"price":12.62,"value":262634.82,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $12.50 to $12.84. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":216162,"source":{"system":"sec-edgar","filing":"0001346164-25-000005","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616425000005/primarydocument.xml","form_type":"4"}},{"id":1029112,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-10-01T21:02:14.000Z","date":"2025-09-29","kind":"sale","planned":true,"acquired":false,"shares":7624,"price":10.03,"value":76468.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.00 to $10.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":236973,"source":{"system":"sec-edgar","filing":"0001346164-25-000003","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000134616425000003/primarydocument.xml","form_type":"4"}},{"id":1041307,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-09-12T20:30:45.000Z","date":"2025-09-10","kind":"sale","planned":true,"acquired":false,"shares":7734,"price":10.02,"value":77494.68,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $10.00 to $10.07. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":244597,"source":{"system":"sec-edgar","filing":"0001562180-25-006194","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025006194/primarydocument.xml","form_type":"4"}},{"id":1092019,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-07-03T22:53:52.000Z","date":"2025-07-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":4701,"price":8.23,"value":38689.23,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on July 1, 2024. The number of shares withheld was\ndetermined based on the closing price of the issuer's common stock on July 1, 2025."}],"balance_after":252331,"source":{"system":"sec-edgar","filing":"0001562180-25-005334","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025005334/primarydocument.xml","form_type":"4"}},{"id":1303237,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-14T22:19:54.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":478606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while\nthe optionee provides continuous service to the Issuer."}],"balance_after":478606,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":478606},"source":{"system":"sec-edgar","filing":"0001562180-25-000360","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025000360/primarydocument.xml","form_type":"4/A","original_submission_date":"2025-01-06"}},{"id":1309901,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2025-01-06T21:59:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":476606,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2026 while the optionee provides continuous service to the Issuer."}],"balance_after":476606,"derivative":{"exercise_price":7.86,"expiration_date":"2035-01-02","underlying":"Common Stock","underlying_shares":476606},"source":{"system":"sec-edgar","filing":"0001562180-25-000188","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025000188/primarydocument.xml","form_type":"4"}},{"id":1309900,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:22.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":98912,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2026, January 1, 2027, January 1, 2028 and January 1, 2029 while the recipient provides continuous service to the Issuer."}],"balance_after":257032,"source":{"system":"sec-edgar","filing":"0001562180-25-000188","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025000188/primarydocument.xml","form_type":"4"}},{"id":1309899,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2025-01-06T21:59:22.000Z","date":"2025-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":11917,"price":7.73,"value":92118.41,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022, January 3, 2023 and January 2, 2024. The number of shares withheld was determined on January 2, 2025 based on the closing price of the issuer's common stock on December 31, 2024."}],"balance_after":158120,"source":{"system":"sec-edgar","filing":"0001562180-25-000188","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218025000188/primarydocument.xml","form_type":"4"}},{"id":1440509,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-08-05T22:39:05.000Z","date":"2024-08-01","kind":"sale","planned":true,"acquired":false,"shares":100,"price":15,"value":1500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan as adopted on March 15, 2024."}],"balance_after":170037,"source":{"system":"sec-edgar","filing":"0001562180-24-006014","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218024006014/primarydocument.xml","form_type":"4"}},{"id":1446139,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-30T21:01:36.000Z","date":"2024-07-29","kind":"sale","planned":true,"acquired":false,"shares":9648,"price":15.04,"value":145105.92,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $15.00 to $15.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":170137,"source":{"system":"sec-edgar","filing":"0001562180-24-005874","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218024005874/primarydocument.xml","form_type":"4"}},{"id":1459556,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Stock Options (Right to Buy)","published_at":"2024-07-03T11:56:30.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":272189,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option vesting commencement date shall be July 1, 2024. The options shall have a term of 10 years from the date of grant, subject to continuous service of the optionee to the Issuer.  The options shall become exercisable as follows: with respect to 1/4th of the shares subject to the option when the optionee completes 12 months of continuous service to the Issuer after the vesting commencement date, and with respect to 1/48th of the shares subject to the option when the optionee completes each month of continuous service to the Issuer thereafter."}],"balance_after":272189,"derivative":{"exercise_price":11.07,"expiration_date":"2034-07-01","underlying":"Common Stock","underlying_shares":272189},"source":{"system":"sec-edgar","filing":"0001562180-24-005567","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218024005567/primarydocument.xml","form_type":"4"}},{"id":1459555,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-07-03T11:56:30.000Z","date":"2024-07-01","kind":"grant","planned":false,"acquired":true,"shares":56458,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"The restricted stock unit (RSU) award vesting commencement date shall be July 1, 2024. 1/4th of the shares subject to the RSU shall vest on each of the first, second, third and fourth anniversaries of the first day of the month in which the RSU was granted, subject to the continuous service of the recipient to the Issuer."}],"balance_after":179785,"source":{"system":"sec-edgar","filing":"0001562180-24-005567","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218024005567/primarydocument.xml","form_type":"4"}},{"id":1687215,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2024-01-04T21:34:19.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":61050,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2025 while the optionee provides continuous service to the Issuer."}],"balance_after":61050,"derivative":{"exercise_price":18.34,"expiration_date":"2034-01-02","underlying":"Common Stock","underlying_shares":61050},"source":{"system":"sec-edgar","filing":"0001562180-24-000257","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218024000257/primarydocument.xml","form_type":"4"}},{"id":1687214,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:34:19.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":38462,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2025, January 1, 2026, January 1, 2027 and January 1, 2028 while the recipient provides continuous service to the Issuer."}],"balance_after":123327,"source":{"system":"sec-edgar","filing":"0001562180-24-000257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218024000257/primarydocument.xml","form_type":"4"}},{"id":1687213,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2024-01-04T21:34:19.000Z","date":"2024-01-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":8120,"price":17.95,"value":145754.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021, January 3, 2022 and January 3, 2023. The number of shares withheld was determined on January 2, 2024 based on the closing price of the issuer's common stock on December 29, 2023."}],"balance_after":84865,"source":{"system":"sec-edgar","filing":"0001562180-24-000257","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218024000257/primarydocument.xml","form_type":"4"}},{"id":2061942,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Stock Options (Right to buy)","published_at":"2023-01-05T21:06:38.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":52986,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 48 months following January 3, 2024 while the optionee provides continuous service to the Issuer."}],"balance_after":52986,"derivative":{"exercise_price":22.25,"expiration_date":"2033-01-03","underlying":"Common Stock","underlying_shares":52986},"source":{"system":"sec-edgar","filing":"0001562180-23-000223","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218023000223/primarydocument.xml","form_type":"4"}},{"id":2061941,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2023-01-05T21:06:38.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":67945,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F2","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2024, January 1, 2025, January 1, 2026 and January 1, 2027 while the recipient provides continuous service to the Issuer."}],"balance_after":92985,"source":{"system":"sec-edgar","filing":"0001562180-23-000223","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218023000223/primarydocument.xml","form_type":"4"}},{"id":2061940,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2023-01-05T21:06:38.000Z","date":"2023-01-03","kind":"tax_withholding","acquired":false,"shares":2076,"price":22.68,"value":47083.68,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock withheld to pay taxes upon the vesting of restricted stock units originally granted to the reporting person on January 4, 2021 and January 3, 2022. The number of shares withheld was determined on January 3, 2023 based on the closing price of the issuer's common stock on December 30, 2022."}],"balance_after":25040,"source":{"system":"sec-edgar","filing":"0001562180-23-000223","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218023000223/primarydocument.xml","form_type":"4"}},{"id":2447895,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2022-01-05T02:06:14.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":51100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2023 while the optionee provides continuous service to the Issuer."}],"balance_after":51100,"derivative":{"exercise_price":34.31,"expiration_date":"2032-01-03","underlying":"Common Stock","underlying_shares":51100},"source":{"system":"sec-edgar","filing":"0001562180-22-000168","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218022000168/primarydocument.xml","form_type":"4"}},{"id":2447894,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:06:14.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2023, January 1, 2024, January 1, 2025 and January 1, 2026 while the recipient provides continuous service to the Issuer."}],"balance_after":27116,"source":{"system":"sec-edgar","filing":"0001562180-22-000168","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218022000168/primarydocument.xml","form_type":"4"}},{"id":2447893,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2022-01-05T02:06:14.000Z","date":"2022-01-01","kind":"tax_withholding","acquired":false,"shares":1332,"price":32.7,"value":43556.4,"ownership":{"direct":true},"balance_after":16416,"source":{"system":"sec-edgar","filing":"0001562180-22-000168","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218022000168/primarydocument.xml","form_type":"4"}},{"id":2906957,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-14T23:55:55.000Z","date":"2021-01-14","kind":"exercise","acquired":false,"shares":10372,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":17128,"derivative":{"exercise_price":35.8,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":10372},"source":{"system":"sec-edgar","filing":"0001562180-21-000345","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000345/primarydocument.xml","form_type":"4"}},{"id":2906956,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-14T23:55:55.000Z","date":"2021-01-14","kind":"exercise","acquired":false,"shares":1240,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":1240},"source":{"system":"sec-edgar","filing":"0001562180-21-000345","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000345/primarydocument.xml","form_type":"4"}},{"id":2906955,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-14T23:55:55.000Z","date":"2021-01-12","kind":"exercise","acquired":false,"shares":1700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":1240,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":1700},"source":{"system":"sec-edgar","filing":"0001562180-21-000345","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000345/primarydocument.xml","form_type":"4"}},{"id":2906954,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2021-01-14T23:55:55.000Z","date":"2021-01-14","kind":"sale","acquired":false,"shares":11612,"price":50.01,"value":580716.12,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17748,"source":{"system":"sec-edgar","filing":"0001562180-21-000345","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000345/primarydocument.xml","form_type":"4"}},{"id":2906953,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2021-01-14T23:55:55.000Z","date":"2021-01-14","kind":"exercise","acquired":true,"shares":10372,"price":35.8,"value":371317.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":29360,"source":{"system":"sec-edgar","filing":"0001562180-21-000345","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000345/primarydocument.xml","form_type":"4"}},{"id":2906952,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2021-01-14T23:55:55.000Z","date":"2021-01-14","kind":"exercise","acquired":true,"shares":1240,"price":19.5,"value":24180.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":18988,"source":{"system":"sec-edgar","filing":"0001562180-21-000345","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000345/primarydocument.xml","form_type":"4"}},{"id":2906951,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2021-01-14T23:55:55.000Z","date":"2021-01-12","kind":"sale","acquired":false,"shares":1700,"price":50.03,"value":85051.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.10. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17748,"source":{"system":"sec-edgar","filing":"0001562180-21-000345","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000345/primarydocument.xml","form_type":"4"}},{"id":2906950,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2021-01-14T23:55:55.000Z","date":"2021-01-12","kind":"exercise","acquired":true,"shares":1700,"price":19.5,"value":33150.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":19448,"source":{"system":"sec-edgar","filing":"0001562180-21-000345","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000345/primarydocument.xml","form_type":"4"}},{"id":2910706,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-11T21:29:44.000Z","date":"2021-01-07","kind":"exercise","acquired":false,"shares":5185,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":2940,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":5185},"source":{"system":"sec-edgar","filing":"0001562180-21-000284","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000284/primarydocument.xml","form_type":"4"}},{"id":2910705,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2021-01-11T21:29:44.000Z","date":"2021-01-07","kind":"sale","acquired":false,"shares":5185,"price":50.01,"value":259301.85,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.17. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":17748,"source":{"system":"sec-edgar","filing":"0001562180-21-000284","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000284/primarydocument.xml","form_type":"4"}},{"id":2910704,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2021-01-11T21:29:44.000Z","date":"2021-01-07","kind":"exercise","acquired":true,"shares":5185,"price":19.5,"value":101107.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":22933,"source":{"system":"sec-edgar","filing":"0001562180-21-000284","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000284/primarydocument.xml","form_type":"4"}},{"id":2914874,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2021-01-06T13:55:30.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":62300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 4, 2022 while the optionee provides continuous service to the Issuer."}],"balance_after":62300,"derivative":{"exercise_price":44.97,"expiration_date":"2031-01-04","underlying":"Common Stock","underlying_shares":62300},"source":{"system":"sec-edgar","filing":"0001562180-21-000143","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000143/primarydocument.xml","form_type":"4"}},{"id":2914873,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Oper. & Tech. Officer"}}],"security":"Common Stock","published_at":"2021-01-06T13:55:30.000Z","date":"2021-01-04","kind":"grant","acquired":true,"shares":13800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents shares of common stock underlying a time-based restricted stock unit award (RSU). 25% of the shares subject to this RSU will vest on each of January 1, 2022, January 1, 2023, January 1, 2024 and January 1, 2025 while the recipient provides continuous service to the Issuer."}],"balance_after":17748,"source":{"system":"sec-edgar","filing":"0001562180-21-000143","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218021000143/primarydocument.xml","form_type":"4"}},{"id":3276471,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-11","kind":"exercise","acquired":false,"shares":6633,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":22,"expiration_date":"2025-08-30","underlying":"Common Stock","underlying_shares":6633},"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":11,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276470,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":4253,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F7","text":"The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":8125,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":4253},"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":10,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276469,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":14928,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":6633,"derivative":{"exercise_price":22,"expiration_date":"2025-08-30","underlying":"Common Stock","underlying_shares":14928},"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276468,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-10","kind":"exercise","acquired":false,"shares":12479,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":27500,"derivative":{"exercise_price":35.8,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":12479},"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276467,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-11","kind":"sale","acquired":false,"shares":3692,"price":51.37,"value":189658.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $51.07 to $51.74. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":3948,"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276466,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-11","kind":"sale","acquired":false,"shares":8872,"price":50.13,"value":444753.36,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.70. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":7640,"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276465,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-11","kind":"exercise","acquired":true,"shares":6633,"price":22,"value":145926.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":16512,"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276464,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-10","kind":"sale","acquired":false,"shares":44429,"price":50.22,"value":2231224.38,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":9879,"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276463,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":12479,"price":35.8,"value":446748.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":54308,"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276462,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":14928,"price":22,"value":328416.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":41829,"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3276461,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-12T21:27:21.000Z","date":"2020-02-10","kind":"exercise","acquired":true,"shares":4253,"price":19.5,"value":82933.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":26901,"source":{"system":"sec-edgar","filing":"0001562180-20-001112","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001112/primarydocument.xml","form_type":"4"}},{"id":3284197,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"exercise","acquired":false,"shares":2708,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The previously granted option, representing a right to purchase a total of 10,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":0,"derivative":{"exercise_price":13.09,"expiration_date":"2026-01-27","underlying":"Common Stock","underlying_shares":2708},"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3284196,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"exercise","acquired":false,"shares":1000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":12378,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":1000},"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3284195,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"exercise","acquired":false,"shares":958,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":21561,"derivative":{"exercise_price":22,"expiration_date":"2025-08-30","underlying":"Common Stock","underlying_shares":958},"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3284194,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"exercise","acquired":false,"shares":471,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":39979,"derivative":{"exercise_price":35.8,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":471},"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3284193,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"sale","acquired":false,"shares":5637,"price":50,"value":281850.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.05. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":22648,"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3284192,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"exercise","acquired":true,"shares":471,"price":35.8,"value":16861.8,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":28285,"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3284191,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"exercise","acquired":true,"shares":958,"price":22,"value":21076.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":27814,"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3284190,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"exercise","acquired":true,"shares":1000,"price":19.5,"value":19500.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":26856,"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3284189,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-02-07T21:23:52.000Z","date":"2020-02-05","kind":"exercise","acquired":true,"shares":2708,"price":13.09,"value":35447.72,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":25856,"source":{"system":"sec-edgar","filing":"0001562180-20-001015","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020001015/primarydocument.xml","form_type":"4"}},{"id":3306206,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-21T21:18:50.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":1622,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":13378,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":1622},"source":{"system":"sec-edgar","filing":"0001562180-20-000454","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020000454/primarydocument.xml","form_type":"4"}},{"id":3306205,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-21T21:18:50.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":2700,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vested in equal monthly installments over the 36 months thereafter."}],"balance_after":22519,"derivative":{"exercise_price":22,"expiration_date":"2025-08-30","underlying":"Common Stock","underlying_shares":2700},"source":{"system":"sec-edgar","filing":"0001562180-20-000454","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020000454/primarydocument.xml","form_type":"4"}},{"id":3306204,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-21T21:18:50.000Z","date":"2020-01-17","kind":"exercise","acquired":false,"shares":800,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":40450,"derivative":{"exercise_price":35.8,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":800},"source":{"system":"sec-edgar","filing":"0001562180-20-000454","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020000454/primarydocument.xml","form_type":"4"}},{"id":3306203,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-01-21T21:18:50.000Z","date":"2020-01-17","kind":"sale","acquired":false,"shares":5922,"price":50,"value":296100.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.04. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23148,"source":{"system":"sec-edgar","filing":"0001562180-20-000454","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020000454/primarydocument.xml","form_type":"4"}},{"id":3306202,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-01-21T21:18:50.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":800,"price":35.8,"value":28640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":29070,"source":{"system":"sec-edgar","filing":"0001562180-20-000454","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020000454/primarydocument.xml","form_type":"4"}},{"id":3306201,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-01-21T21:18:50.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":2700,"price":22,"value":59400.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":28270,"source":{"system":"sec-edgar","filing":"0001562180-20-000454","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020000454/primarydocument.xml","form_type":"4"}},{"id":3306200,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2020-01-21T21:18:50.000Z","date":"2020-01-17","kind":"exercise","acquired":true,"shares":1622,"price":19.5,"value":31629.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":25570,"source":{"system":"sec-edgar","filing":"0001562180-20-000454","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020000454/primarydocument.xml","form_type":"4"}},{"id":3317726,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2020-01-06T21:24:48.000Z","date":"2020-01-02","kind":"grant","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 2, 2021 while the optionee provides continuous service to the Issuer."}],"balance_after":46000,"derivative":{"exercise_price":38.99,"expiration_date":"2030-01-02","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001562180-20-000219","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218020000219/primarydocument.xml","form_type":"4"}},{"id":3344966,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-12-11T21:24:18.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":6153,"price":44.26,"value":272331.78,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to the Reporting Person's election under the Issuer's equity incentive plan and applicable award agreement to satisfy tax withholding obligations through a \"sell to cover\" transaction in connection with the vesting of 39,500 restricted stock unit shares awarded on December 8, 2016. This sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $44.04 to $44.96. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":23948,"source":{"system":"sec-edgar","filing":"0001562180-19-006017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019006017/primarydocument.xml","form_type":"4"}},{"id":3344965,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-12-11T21:24:18.000Z","date":"2019-12-09","kind":"sale","acquired":false,"shares":9399,"price":43.4,"value":407916.6,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This sale was made pursuant to the Reporting Person's election under the Issuer's equity incentive plan and applicable award agreement to satisfy tax withholding obligations through a \"sell to cover\" transaction in connection with the vesting of 39,500 restricted stock unit shares awarded on December 8, 2016. This sale does not represent a discretionary trade by the Reporting Person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $43.038 to $44.03. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":30101,"source":{"system":"sec-edgar","filing":"0001562180-19-006017","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019006017/primarydocument.xml","form_type":"4"}},{"id":3507281,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-05-30T20:56:09.000Z","date":"2019-05-28","kind":"exercise","acquired":false,"shares":18000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":25219,"derivative":{"exercise_price":22,"expiration_date":"2025-08-30","underlying":"Common Stock","underlying_shares":18000},"source":{"system":"sec-edgar","filing":"0001562180-19-003180","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019003180/primarydocument.xml","form_type":"4"}},{"id":3507280,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-05-30T20:56:09.000Z","date":"2019-05-28","kind":"sale","acquired":false,"shares":18000,"price":50,"value":900000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":39500,"source":{"system":"sec-edgar","filing":"0001562180-19-003180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019003180/primarydocument.xml","form_type":"4"}},{"id":3507279,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-05-30T20:56:09.000Z","date":"2019-05-28","kind":"exercise","acquired":true,"shares":18000,"price":22,"value":396000.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":57500,"source":{"system":"sec-edgar","filing":"0001562180-19-003180","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019003180/primarydocument.xml","form_type":"4"}},{"id":3628631,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-27T22:35:10.000Z","date":"2019-02-25","kind":"exercise","acquired":false,"shares":5300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":41250,"derivative":{"exercise_price":35.8,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":5300},"source":{"system":"sec-edgar","filing":"0001562180-19-001472","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019001472/primarydocument.xml","form_type":"4"}},{"id":3628630,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-02-27T22:35:10.000Z","date":"2019-02-25","kind":"sale","acquired":false,"shares":5300,"price":54.05,"value":286465.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":39500,"source":{"system":"sec-edgar","filing":"0001562180-19-001472","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019001472/primarydocument.xml","form_type":"4"}},{"id":3628629,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-02-27T22:35:10.000Z","date":"2019-02-25","kind":"exercise","acquired":true,"shares":5300,"price":35.8,"value":189740.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":44800,"source":{"system":"sec-edgar","filing":"0001562180-19-001472","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019001472/primarydocument.xml","form_type":"4"}},{"id":3670111,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"exercise","acquired":false,"shares":625,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The previously granted option, representing a right to purchase a total of 10,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":2708,"derivative":{"exercise_price":13.09,"expiration_date":"2026-01-27","underlying":"Common Stock","underlying_shares":625},"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3670110,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"exercise","acquired":false,"shares":1875,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":15000,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":1875},"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3670109,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"exercise","acquired":false,"shares":32882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":43219,"derivative":{"exercise_price":22,"expiration_date":"2025-08-30","underlying":"Common Stock","underlying_shares":32882},"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3670108,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"exercise","acquired":false,"shares":8450,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 55,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 3, 2019, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":46550,"derivative":{"exercise_price":35.8,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":8450},"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3670107,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"sale","acquired":false,"shares":43832,"price":50.08,"value":2195106.56,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $50.00 to $50.49. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39500,"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3670106,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"exercise","acquired":true,"shares":625,"price":13.09,"value":8181.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":83332,"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3670105,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"exercise","acquired":true,"shares":1875,"price":19.5,"value":36562.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":82707,"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3670104,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"exercise","acquired":true,"shares":32882,"price":22,"value":723404.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":80832,"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3670103,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Common Stock","published_at":"2019-02-07T21:18:21.000Z","date":"2019-02-05","kind":"exercise","acquired":true,"shares":8450,"price":35.8,"value":302510.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":47950,"source":{"system":"sec-edgar","filing":"0001562180-19-000815","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000815/primarydocument.xml","form_type":"4"}},{"id":3701680,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Product Development & CTO"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-07T21:25:51.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":46000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"25% of the shares subject to this option shall vest after 12 months of continuous service with the Issuer. The balance will vest in equal monthly installments over the 36 months following January 3, 2020 while the optionee provides continuous service to the Issuer."}],"balance_after":46000,"derivative":{"exercise_price":40.82,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":46000},"source":{"system":"sec-edgar","filing":"0001562180-19-000221","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218019000221/primarydocument.xml","form_type":"4"}},{"id":3756114,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-11-20T21:19:17.000Z","date":"2018-11-16","kind":"exercise","acquired":false,"shares":32882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F6","text":"The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":76101,"derivative":{"exercise_price":22,"expiration_date":"2025-08-30","underlying":"Common Stock","underlying_shares":32882},"source":{"system":"sec-edgar","filing":"0001562180-18-004631","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004631/primarydocument.xml","form_type":"4"}},{"id":3756113,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-11-20T21:19:17.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":15494,"price":64.71,"value":1002616.74,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F5","text":"This transaction was executed in multiple trades at prices ranging from $64.30 to $65.16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":39500,"source":{"system":"sec-edgar","filing":"0001562180-18-004631","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004631/primarydocument.xml","form_type":"4"}},{"id":3756112,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-11-20T21:19:17.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":6505,"price":63.64,"value":413978.2,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F4","text":"This transaction was executed in multiple trades at prices ranging from $63.27 to $64.255. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":54994,"source":{"system":"sec-edgar","filing":"0001562180-18-004631","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004631/primarydocument.xml","form_type":"4"}},{"id":3756111,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-11-20T21:19:17.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":6883,"price":62.79,"value":432183.57,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $62.25 to $63.20. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":61499,"source":{"system":"sec-edgar","filing":"0001562180-18-004631","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004631/primarydocument.xml","form_type":"4"}},{"id":3756110,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-11-20T21:19:17.000Z","date":"2018-11-16","kind":"sale","acquired":false,"shares":4000,"price":61.91,"value":247640.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $61.21 to $62.18. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected."}],"balance_after":68382,"source":{"system":"sec-edgar","filing":"0001562180-18-004631","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004631/primarydocument.xml","form_type":"4"}},{"id":3756109,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-11-20T21:19:17.000Z","date":"2018-11-16","kind":"exercise","acquired":true,"shares":32882,"price":22,"value":723404.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":72382,"source":{"system":"sec-edgar","filing":"0001562180-18-004631","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004631/primarydocument.xml","form_type":"4"}},{"id":3787371,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-18T20:24:00.000Z","date":"2018-10-16","kind":"exercise","acquired":false,"shares":2667,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The previously granted option, representing a right to purchase a total of 10,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 28, 2017, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":3333,"derivative":{"exercise_price":13.09,"expiration_date":"2026-01-27","underlying":"Common Stock","underlying_shares":2667},"source":{"system":"sec-edgar","filing":"0001562180-18-004249","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004249/primarydocument.xml","form_type":"4"}},{"id":3787370,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-18T20:24:00.000Z","date":"2018-10-16","kind":"exercise","acquired":false,"shares":13125,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The previously granted option, representing a right to purchase a total of 30,000 shares, became exercisable as follows: 25% of the shares subject to this option vested on January 4, 2018, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":16875,"derivative":{"exercise_price":19.5,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":13125},"source":{"system":"sec-edgar","filing":"0001562180-18-004249","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004249/primarydocument.xml","form_type":"4"}},{"id":3787369,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Stock Option (Right to Buy)","published_at":"2018-10-18T20:24:00.000Z","date":"2018-10-16","kind":"exercise","acquired":false,"shares":46517,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The previously granted option, representing a right to purchase a total of 230,500 shares, became exercisable as follows: 25% of the shares subject to this option vested on August 31, 2016, and the balance vests in equal monthly installments over the 36 months thereafter while the optionee provides continuous service to the Issuer."}],"balance_after":108983,"derivative":{"exercise_price":22,"expiration_date":"2025-08-30","underlying":"Common Stock","underlying_shares":46517},"source":{"system":"sec-edgar","filing":"0001562180-18-004249","document":"primarydocument.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004249/primarydocument.xml","form_type":"4"}},{"id":3787368,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-10-18T20:24:00.000Z","date":"2018-10-16","kind":"sale","acquired":false,"shares":2667,"price":60.85,"value":162286.95,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":39500,"source":{"system":"sec-edgar","filing":"0001562180-18-004249","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004249/primarydocument.xml","form_type":"4"}},{"id":3787367,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-10-18T20:24:00.000Z","date":"2018-10-16","kind":"exercise","acquired":true,"shares":2667,"price":13.09,"value":34911.03,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":42167,"source":{"system":"sec-edgar","filing":"0001562180-18-004249","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004249/primarydocument.xml","form_type":"4"}},{"id":3787366,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-10-18T20:24:00.000Z","date":"2018-10-16","kind":"sale","acquired":false,"shares":13125,"price":60.85,"value":798656.25,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":39500,"source":{"system":"sec-edgar","filing":"0001562180-18-004249","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004249/primarydocument.xml","form_type":"4"}},{"id":3787365,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-10-18T20:24:00.000Z","date":"2018-10-16","kind":"exercise","acquired":true,"shares":13125,"price":19.5,"value":255937.5,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":52625,"source":{"system":"sec-edgar","filing":"0001562180-18-004249","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004249/primarydocument.xml","form_type":"4"}},{"id":3787364,"issuer":{"id":2211,"kind":"organization","name":"REGENXBIO Inc.","symbol":"RGNX"},"owners":[{"id":32052,"kind":"person","name":"Simpson Curran","position":1,"cik":"0001346164","reported_name":"Simpson Curran","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Technical Operations"}}],"security":"Common Stock","published_at":"2018-10-18T20:24:00.000Z","date":"2018-10-16","kind":"sale","acquired":false,"shares":46517,"price":60.85,"value":2830559.45,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":39500,"source":{"system":"sec-edgar","filing":"0001562180-18-004249","document":"primarydocument.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1346164/000156218018004249/primarydocument.xml","form_type":"4"}}],"next_cursor":"2018-10-18T20:24:00.000000Z,3787364"}